AMCILL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amcill, and when can generic versions of Amcill launch?
Amcill is a drug marketed by Parke Davis and is included in two NDAs.
The generic ingredient in AMCILL is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.
Summary for AMCILL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 4,141 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMCILL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AMCILL
US Patents and Regulatory Information for AMCILL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | AMCILL | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062041-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | AMCILL | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 062030-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | AMCILL | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062041-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | AMCILL | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 062030-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |